Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience

2013255 citationsJournal Article

Authors

Good health and well-being

Published in: Cancer Chemotherapy and Pharmacology

Volume 71, Issue 3, pp. 663-670

Field-Weighted Citation Impact: 14.24